[1]
|
Kalluri, R. and Weinberg, R.A. (2009) The Basics of Epithelial-Mesenchymal Transition. Journal of Clinical Investigation, 119, 1420-1428.
https://doi.org/10.1172/JCI39104
|
[2]
|
Lima, J.F., Nofech-Mozes, S., Bayani, J. and Bartlett, J.M.S. (2016) EMT in Breast Carcinoma—A Review. Journal of Clinical Medicine, 5, 65.
https://doi.org/10.3390/jcm5070065
|
[3]
|
Alonso-Magdalena, P., Brossner, C., Reiner, A., Cheng, G., Sugiyama, N., Warner, M. and Gustafsson, J.A. (2009) A Role for Epithelial-Mesenchymal Transition in the Etiology of Benign Prostatic Hyperplasia. Proceedings of the National Academy of Sciences of the United States of America, 106, 2859-2863.
https://doi.org/10.1073/pnas.0812666106
|
[4]
|
Prajapati, A., et al. (2013) Prostate Stem Cells in the Development of Benign Prostate Hyperplasia and Prostate Cancer: Emerging Role and Concepts. BioMed Research International, 2013, Article ID: 107954.
|
[5]
|
Li, P., et al. (2014) Contributions of Epithelial-Mesenchymal Transition and Cancer Stem Cells to the Development of Castration Resistance of Prostate Cancer. Molecular Cancer, 13, 55. https://doi.org/10.1186/1476-4598-13-55
|
[6]
|
Marin-Aguilera, M., Codony-Servat, J., Reig, O., et al. (2014) Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer. Molecular Cancer Therapeutics, 13, 1270-1284.
|
[7]
|
Shi, X., Gipp, J., Dries, M. and Bushman, W. (2014) Prostate Progenitor Cells Proliferation in Response to Castration. Stem Cell Research, 13, 154-163.
https://doi.org/10.1016/j.scr.2014.04.005
|
[8]
|
Kim, S.W., Roh, J. and Park, C.S. (2016) Immunohistochemistry for Pathologists: Protocols, Pitfalls, and Tips. Journal of Pathology and Translational Medicine, 50, 411-418. https://doi.org/10.4132/jptm.2016.08.08
|
[9]
|
Grant, C.M. and Kyprianou, N. (2013) Epithelial Mesenchymal Transition (EMT) in Prostate Growth and Tumor Progression. Translational Andrology and Urology, 2, 202-211.
|
[10]
|
Sun, Y., Wang, B.-E., Leong, K.G., Yue, P., Li, L., Jhunjhunwala, S., Chen, D., et al. (2011) Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy. Cancer Research, 7, 527-536.
|
[11]
|
Moltzahn, F. and Thalmann, G.N. (2013) Cancer Stem Cells in Prostate Cancer. Translational Andrology and Urology, 2, 242-253.
|
[12]
|
Stoyanova, T., Cooper, A.R., Drake, J.M., Liu, X., Armstrong, A.J., Pienta, K.J., et al. (2013) Ptostate Cancer Originating in Basal Cells Progress to Adenocarcinoma Propagated by Luminal-Like Cells. Proceedings of the National Academy of Sciences of the United States of America, 110, 20111-20116.
https://doi.org/10.1073/pnas.1320565110
|
[13]
|
Toivanen, R., Mohan, A. and Shen, M.M. (2016) Basal Progenitors Contribute to Repair of the Prostate Epithelium Following Induced Luminal Anoikis. Stem Cell Reports, 6, 660-667. https://doi.org/10.1016/j.stemcr.2016.03.007
|
[14]
|
Brocqueville, G., Chmelar, R.S., Bauderlique-Le Roy, H., Deruy, E., Tian, L., Vessella, R.L., Greenberg, N.M., Rohrschneider, L.R. and Bourette, R.P. (2016) s-SHIP Expression Identifies a Subset of Murine Basal Prostate Cells as Neonatal Stem Cells. Oncotarget, 7, 29228-29244.
|
[15]
|
Kwon, O.J., Zhang, B., Zhang, L. and Xin, L. (2016) High Diet Promotes Prostatic Basal-to-Luminal Differentiation and Accelerates Initiation of Prostate Epithelial Hyperplasia Originated from Basal Cells. Stem Cell Research, 16, 682-691.
https://doi.org/10.1016/j.scr.2016.04.009
|
[16]
|
Wei, X., Orjalo, A.V. and Xin, L. (2016) CD133 Does Not Enrich for the Stem Cell Activity in vivo in Adult Mouse Prostates. Stem Cell Research, 16, 597-606.
https://doi.org/10.1016/j.scr.2016.03.003
|
[17]
|
Xu, H., Tian, Y., Yuan, X., Wu, H., Liu, Q., Pestell, R.G. and Wu, K. (2015) The Role of CD44 in Epithelial-Mesenchymal Transition and Cancer Development. OncoTargets and Therapy, 8, 3783-3792.
|
[18]
|
Shang, Z., Cai, Q., Zhang, M., Zhu, S., Ma, Y., Sun, L., Jiang, N., et al. (2014) A Switch from CD44+ Cell to EMT Cell Drives the Metastasis of Prostate Cancer. Oncotarget, 6, 1202-1216.
|
[19]
|
Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun-Davis, T., Li, H., et al. (2011) Identification of miR-34a as a Potent Inhibitor of Prostate Cancer Progenitor Cells and Metastasis by Directory Repressing CD44. Nature Medicine, 17, 211-215.
https://doi.org/10.1038/nm.2284
|
[20]
|
Kalluri, R. and Weinberg, R.A. (2009) The Basics of Epithelial-Mesenchymal Transition. Journal of Clinical Investigation, 119, 1420-1428.
https://doi.org/10.1172/JCI39104
|
[21]
|
Lima, J.F., Nofech-Mozes, S., Bayani, J. and Bartlett, J.M.S. (2016) EMT in Breast Carcinoma—A Review. Journal of Clinical Medicine, 5, 65.
https://doi.org/10.3390/jcm5070065
|
[22]
|
Alonso-Magdalena, P., Brossner, C., Reiner, A., Cheng, G., Sugiyama, N., Warner, M. and Gustafsson, J.A. (2009) A Role for Epithelial-Mesenchymal Transition in the Etiology of Benign Prostatic Hyperplasia. Proceedings of the National Academy of Sciences of the United States of America, 106, 2859-2863.
https://doi.org/10.1073/pnas.0812666106
|
[23]
|
Prajapati, A., et al. (2013) Prostate Stem Cells in the Development of Benign Prostate Hyperplasia and Prostate Cancer: Emerging Role and Concepts. BioMed Research International, 2013, Article ID: 107954.
|
[24]
|
Li, P., et al. (2014) Contributions of Epithelial-Mesenchymal Transition and Cancer Stem Cells to the Development of Castration Resistance of Prostate Cancer. Molecular Cancer, 13, 55. https://doi.org/10.1186/1476-4598-13-55
|
[25]
|
Marin-Aguilera, M., Codony-Servat, J., Reig, O., et al. (2014) Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer. Molecular Cancer Therapeutics, 13, 1270-1284.
|
[26]
|
Shi, X., Gipp, J., Dries, M. and Bushman, W. (2014) Prostate Progenitor Cells Proliferation in Response to Castration. Stem Cell Research, 13, 154-163.
https://doi.org/10.1016/j.scr.2014.04.005
|
[27]
|
Kim, S.W., Roh, J. and Park, C.S. (2016) Immunohistochemistry for Pathologists: Protocols, Pitfalls, and Tips. Journal of Pathology and Translational Medicine, 50, 411-418. https://doi.org/10.4132/jptm.2016.08.08
|
[28]
|
Grant, C.M. and Kyprianou, N. (2013) Epithelial Mesenchymal Transition (EMT) in Prostate Growth and Tumor Progression. Translational Andrology and Urology, 2, 202-211.
|
[29]
|
Sun, Y., Wang, B.-E., Leong, K.G., Yue, P., Li, L., Jhunjhunwala, S., Chen, D., et al. (2011) Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy. Cancer Research, 7, 527-536.
|
[30]
|
Moltzahn, F. and Thalmann, G.N. (2013) Cancer Stem Cells in Prostate Cancer. Translational Andrology and Urology, 2, 242-253.
|
[31]
|
Stoyanova, T., Cooper, A.R., Drake, J.M., Liu, X., Armstrong, A.J., Pienta, K.J., et al. (2013) Ptostate Cancer Originating in Basal Cells Progress to Adenocarcinoma Propagated by Luminal-Like Cells. Proceedings of the National Academy of Sciences of the United States of America, 110, 20111-20116.
https://doi.org/10.1073/pnas.1320565110
|
[32]
|
Toivanen, R., Mohan, A. and Shen, M.M. (2016) Basal Progenitors Contribute to Repair of the Prostate Epithelium Following Induced Luminal Anoikis. Stem Cell Reports, 6, 660-667. https://doi.org/10.1016/j.stemcr.2016.03.007
|
[33]
|
Brocqueville, G., Chmelar, R.S., Bauderlique-Le Roy, H., Deruy, E., Tian, L., Vessella, R.L., Greenberg, N.M., Rohrschneider, L.R. and Bourette, R.P. (2016) s-SHIP Expression Identifies a Subset of Murine Basal Prostate Cells as Neonatal Stem Cells. Oncotarget, 7, 29228-29244.
|
[34]
|
Kwon, O.J., Zhang, B., Zhang, L. and Xin, L. (2016) High Diet Promotes Prostatic Basal-to-Luminal Differentiation and Accelerates Initiation of Prostate Epithelial Hyperplasia Originated from Basal Cells. Stem Cell Research, 16, 682-691.
https://doi.org/10.1016/j.scr.2016.04.009
|
[35]
|
Wei, X., Orjalo, A.V. and Xin, L. (2016) CD133 Does Not Enrich for the Stem Cell Activity in vivo in Adult Mouse Prostates. Stem Cell Research, 16, 597-606.
https://doi.org/10.1016/j.scr.2016.03.003
|
[36]
|
Xu, H., Tian, Y., Yuan, X., Wu, H., Liu, Q., Pestell, R.G. and Wu, K. (2015) The Role of CD44 in Epithelial-Mesenchymal Transition and Cancer Development. OncoTargets and Therapy, 8, 3783-3792.
|
[37]
|
Shang, Z., Cai, Q., Zhang, M., Zhu, S., Ma, Y., Sun, L., Jiang, N., et al. (2014) A Switch from CD44+ Cell to EMT Cell Drives the Metastasis of Prostate Cancer. Oncotarget, 6, 1202-1216.
|
[38]
|
Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun-Davis, T., Li, H., et al. (2011) Identification of miR-34a as a Potent Inhibitor of Prostate Cancer Progenitor Cells and Metastasis by Directory Repressing CD44. Nature Medicine, 17, 211-215.
https://doi.org/10.1038/nm.2284
|